Colorectal Cancer CME

• Liver Imaging with MRI CME Subtle cues derived from well-selected imaging sequences can distinguish benign and malignant masses and hepatic lesions from metastases.
  Medscape Education Radiology, February 2012
• Challenges in the Management of Older Patients With Colon Cancer CME Should physicians routinely employ surgery and chemotherapy in the management of colon cancer among older adults? The current review provides answers.
  JNCCN - Journal of the National Comprehensive Cancer Network, February 2012
• Improving Protection Against Proximal Colon Cancer by Colonoscopy CME How effective is colonoscopy in preventing serious outcomes related to proximal colon cancer? The current review answers this question as well as provides suggestions to improve colonoscopic techniques.
  Expert Review of Gastroenterology and Hepatology, December 2011
• CT Colonography Leads to Better Cancer Screening Participation CME More patients participated in computed tomographic colonography vs traditional colonoscopy for cancer screening, according to a new study conducted in the Netherlands.
  Medscape Education Clinical Briefs, November 2011
• Aspirin Regimen Recommended in Patients With Hereditary Cancer CME/CE In a decade-long trial, an aspirin regimen reduced the risk for the development of cancer (including colon cancer) by half in individuals with Lynch syndrome.
  November 2011
• The Current Landscape of Locally Advanced Rectal Cancer CME Innovations in treatment have improved outcomes in cases of locally advanced rectal cancer. The current review evaluates the best practice in the treatment of this tumor.
  Nature Reviews Clinical Oncology, November 2011
• Biomarker Use in Colorectal Cancer Therapy CME Biomarkers for colorectal cancers can help guide clinical management and may allow enrichment, stratification, and identification of novel therapeutic targets in drug development.
  JNCCN - Journal of the National Comprehensive Cancer Network, November 2011
• FDA Safety Changes: Bevacizumab Label Revised With New Risks CME/CE The FDA has issued a revised label for bevacizumab to warn of an increased risk for ovarian failure, along with the risks for osteonecrosis of the jaw and venous thromboembolic events.
  Medscape Education Clinical Briefs, October 2011
• Alcohol Use Associated With Colorectal Cancer Risk CME According to a new meta-analysis, alcohol consumption appeared to be strongly associated with the risk for colorectal cancer in a dose-dependent manner.
  Medscape Education Clinical Briefs, September 2011
• Study Confirms One-Time Sigmoidoscopy Reduced Colorectal Cancer Incidence CME A new study confirmed that previous UK results about a single flexible sigmoidoscopy performed between the ages of 55 and 64 years was a safe, effective means of colorectal cancer screening.
  Medscape Education Clinical Briefs, September 2011
• Right-Sided Colon Retroflexion Safe, Detects Additional Adenomas CME A current study found that right-sided colon retroflexion is generally achievable and safe, with yield comparable to that expected from a second examination in the forward view.
  Medscape Education Clinical Briefs, August 2011
• Refining the Role of Anti-EGFR Antibodies in Metastatic Colorectal Cancer   CME Drs. Weiner, Meropol, Van Cutsem, and Lenz discuss 2 patients with mCRC, 1 with liver-limited disease and 1 with progressive disease.
  Medscape Education Oncology, July 2011
• Changes in Family History of Cancer Major Factor in Screening Assessment CME A new study recommends that clinicians update a patient's family history every 5 to 10 years to determine the best type of cancer screening to assess a patient's level of risk.
  Medscape Education Clinical Briefs, July 2011
• Poor Colonoscopy Preparation Associated With High Adenoma Miss Rates CME When bowel preparation is suboptimal, the efficacy of a colonoscopy in the detection of adenomas is compromised, suggesting the need for an early follow-up colonoscopy.
  Medscape Education Clinical Briefs, June 2011
• Metastasis-Suppressor Genes in Clinical Practice: Lost in Translation? CME Metastasis-suppressor genes may play an important role in the future of cancer care. The current review describes how these genes work and offers insight into their potential for clinical use.
  Nature Reviews Clinical Oncology, June 2011
• Quantitative Fecal Hemoglobin May Predict Colon Cancer Risk CME In a prospective cohort study, quantitative fecal hemoglobin concentration at first screening predicted a subsequent risk for incident colorectal cancer.
  Medscape Education Clinical Briefs, May 2011
• Biomarkers in Metastatic Colorectal Cancer and Response to Anti-EGFR Monoclonal Antibodies   CME Dr. John Marshall describes the evolving use of biomarkers in mCRC and how information about mutational status can be used clinically.
  Medscape Education Oncology, May 2011
• Advanced Colorectal Cancer: Braf Status and Treatment Choices CME Dr. Richard Goldberg clarifies how to use Kras and Braf status testing in patients with mCRC to understand prognosis and predict response to treatment.
  Medscape Education Oncology, April 2011
• Exercise Reduces Risk for Colon Polyps, Resulting in Less Colon Cancer CME Exercise has long been known to reduce the risk of developing colon cancer; now it appears that it does so by reducing the risk for colon polyps.
  Medscape Education Clinical Briefs, March 2011
• ACOG Encourages Ob-Gyns to Recommend Colorectal Screening CME/CE Recommendations call for an emphasis on colonoscopy, but clinicians should discuss other viable options with the patient.
  Medscape Education Clinical Briefs, March 2011